vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
27.35
-0.02 (-0.07%)
Dec 5, 2025, 4:00 PM EST - Market closed
vTv Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for vTv Therapeutics stock have an average target of 37, with a low estimate of 35 and a high estimate of 40. The average target predicts an increase of 35.28% from the current stock price of 27.35.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for vTv Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +46.25% | Nov 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +31.63% | Aug 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +31.63% | Apr 9, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +27.97% | Dec 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $240 | Strong Buy | Reiterates | $240 | +777.51% | Mar 7, 2023 |
Financial Forecast
Revenue This Year
n/a
from 1.02M
Revenue Next Year
n/a
EPS This Year
-4.12
from -3.20
EPS Next Year
-3.82
from -4.12
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.52 | -3.06 | ||||
| Avg | -4.12 | -3.82 | ||||
| Low | -4.83 | -4.14 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.